Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Merck Sharp & Dohme LLC · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
triple-negative-breast-cancer
triple-negative breast cancer, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 861092
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.